Delivery Order #15B10726F00000080

Modification to McKesson Pharmaceutical Prime Vendor Contract Delivery Order

This is a supplemental delivery order under an existing multi-year indefinite delivery vehicle (IDV) contract known as the Pharmaceutical Prime Vendor Contract (PPV). The recipient, McKesson Corporation—a prominent pharmaceutical distribution company—has been awarded this modification to increase accrual funding for a specific order within the broader VA pharmaceutical supply contract. McKesson's role encompasses the delivery of pharmaceutical products to the Department of Veterans Affairs, ensuring veterans have consistent access to essential medications. The modification covers an increment in financial obligations for continued supply duties during a short-term period within the long-term agreement. The original prime contract, a significant award facilitating efficient pharmaceutical distribution valued in the tens of billions, was competitively solicited without set-aside restrictions, emphasizing fair competition. This recent modification signifies ongoing collaboration and contract management to address evolving needs, enhancing the stability of pharmaceutical provisioning to the public health sector.

Description

MCKESSON PHARMACEUTICALS SEPTEMBER 26 FY26 36W79720D0001 MOD TO INCREASE FOR ACCRUAL

View original record